Biotechnology News and Research

RSS

Soligenix starts first clinical study for development of SGX203 for pediatric Crohn's disease

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has initiated the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.

15 May 2013

IFR scientists mine the genome of C. botulinum to reveal new information about toxin genes

The toxin that causes botulism is the most potent that we know of. Eating an amount of toxin just 1000th the weight of a grain of salt can be fatal, which is why so much effort has been put into keeping Clostridium botulinum, which produces the toxin, out of our food.

15 May 2013

Roundup: Ore. Health Co-Ops to compete with big insurers; Texas lawmakers find money for mental health, women's care

Armed with hefty federal loans, two startup health insurers are jumping into a crowded and confusing Oregon market just as the biggest changes to U.S. health care in generations roll out this fall.

15 May 2013

Polymer substance fully resists the body's natural attack response to foreign objects

It's a familiar scenario - a patient receives a medical implant and days later, the body attacks the artificial valve or device, causing complications to an already compromised system.

15 May 2013

Synthetic silicate nanoplatelets can stimulate stem cells to become bone cells

In new research published online May 13, 2013 in Advanced Materials, researchers from Brigham and Women's Hospital are the first to report that synthetic silicate nanoplatelets (also known as layered clay) can induce stem cells to become bone cells without the need of additional bone-inducing factors.

15 May 2013

India's DBT, Bharat Biotech announce positive Phase III clinical trial results of rotavirus vaccine

The Government of India's Department of Biotechnology and Bharat Biotech announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India.

14 May 2013

Study provides evidence of altered circadian gene rhythms in brain tissue of people with depression

UC Irvine Health researchers have helped discover that genes controlling circadian clock rhythms are profoundly altered in the brains of people with severe depression.

14 May 2013

Noninvasive imaging tests may play bigger role in diabetes management

New approaches to applying noninvasive imaging tests such as computed tomography, magnetic resonance, and positron emission tomography may play a bigger role in evaluating and managing patients with diabetes.

14 May 2013

Biogen Idec announces FDA's acceptance of ELOCTATE BLA for treatment of hemophilia A

Biogen Idec announced today that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for the marketing approval of ELOCTATE (recombinant factor VIII Fc fusion protein) for the treatment of hemophilia A.

13 May 2013

ALS-ETF, Denovo partner to explore personalized medicine approach for ALS

The ALS Emergency Treatment Fund and Denovo Biomarkers have announced a partnership to explore using Denovo's technology to identify potential responder groups for drugs being studied in ALS patients.

10 May 2013

Headline results of Creabilis' CT327 Phase 2b trial in psoriasis patients announced

Creabilis, a late stage European dermatology company with a focus on chronic pruritus (itch), today announces headline results of its Phase 2b trial with its lead product, CT327, in psoriasis patients.

10 May 2013

Hidden HIV replication may be occurring within the body's tissue, researchers report

Scientists have long believed that measuring the amount of HIV in a person's blood is an indicator of whether the virus is actively reproducing.

9 May 2013

UA researchers discover genetic mutations that cause severe epilepsies in children

Researchers at the University of Arizona have successfully determined the genetic mutations causing severe epilepsies in seven out of 10 children for whom the cause of the disorder could not be determined clinically or by conventional genetic testing.

9 May 2013

Review for clinicians on optimal utilization of aspirin to treat, prevent heart attacks published

Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University published a review for clinicians on the optimal utilization of aspirin to treat and prevent heart attacks.

9 May 2013

More work needed to understand use of nanosilver, say researchers

Researchers from the University of New South Wales have cautioned that more work is needed to understand how micro-organisms respond to the disinfecting properties of silver nano-particles, increasingly used in medical and environmental applications.

9 May 2013

Aviir to extend comprehensive inherited cardiovascular disease genetic test menu

Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, announced that it will be extending its offered services with comprehensive inherited cardiovascular disease genetic test menu.

8 May 2013

IDIBELL signs patent licensing agreement with Minoryx

The Bellvittge Biomedical Research Institute has signed a licensing agreement with the Spanish biotechnology company Minoryx of a patent for the treatment of X-linked adrenoleukodystrophy, a rare serious neurodegenerative disease which has no effective treatment.

8 May 2013

Cubist receives Fast Track designation from FDA for late-stage antibiotic candidate

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.

8 May 2013

Clinical data of cabozantinib to be presented at ASCO meeting

Exelixis, Inc. announced today that cabozantinib will be the subject of nine separate data presentations at the upcoming 2013 Annual Meeting of the American Society of Clinical Oncology.

8 May 2013

Immunoglobulin fails to meet co-primary endpoints in Phase III clinical study, Baxter reports

Baxter International Inc. today announced that its Phase III clinical study of immunoglobulin did not meet its co-primary endpoints of reducing cognitive decline and preserving functional abilities in patients with mild to moderate Alzheimer's disease.

From Baxter International Inc. 8 May 2013

Biotechnology News and Research

Soligenix starts first clinical study for development of SGX203 for pediatric Crohn's disease

IFR scientists mine the genome of C. botulinum to reveal new information about toxin genes

Roundup: Ore. Health Co-Ops to compete with big insurers; Texas lawmakers find money for mental health, women's care

Polymer substance fully resists the body's natural attack response to foreign objects

Synthetic silicate nanoplatelets can stimulate stem cells to become bone cells

India's DBT, Bharat Biotech announce positive Phase III clinical trial results of rotavirus vaccine

Study provides evidence of altered circadian gene rhythms in brain tissue of people with depression

Noninvasive imaging tests may play bigger role in diabetes management

Biogen Idec announces FDA's acceptance of ELOCTATE BLA for treatment of hemophilia A

ALS-ETF, Denovo partner to explore personalized medicine approach for ALS

Headline results of Creabilis' CT327 Phase 2b trial in psoriasis patients announced

Hidden HIV replication may be occurring within the body's tissue, researchers report

UA researchers discover genetic mutations that cause severe epilepsies in children

Review for clinicians on optimal utilization of aspirin to treat, prevent heart attacks published

More work needed to understand use of nanosilver, say researchers

Aviir to extend comprehensive inherited cardiovascular disease genetic test menu

IDIBELL signs patent licensing agreement with Minoryx

Cubist receives Fast Track designation from FDA for late-stage antibiotic candidate

Clinical data of cabozantinib to be presented at ASCO meeting

Immunoglobulin fails to meet co-primary endpoints in Phase III clinical study, Baxter reports

Biotechnology eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News